C oronary heart disease (CHD) mortality rates have decreased in many countries during the last decades. 1, 2 Both changes in the rates of out-of-hospital CHD deaths and hospitalization rates and the outcome of myocardial infarction (MI) with ST-segment elevation (STEMI) and non-ST-segment elevation (non-STEMI) will affect mortality. 3
1974 to 2008. 11 The present study includes participants from the surveys undertaken in 1994 to 1995, 2001 to 2002, and 2007 to 2008, including a total of 29 582 individuals ≥25 years and older who participated in 1, 2, or all 3 surveys. The attendance rates of the 1994-1995, 2001-2002, and 2007-2008 surveys were 72%, 79% and 66%, respectively. Table I in the online-only Data Supplement shows a summary of the surveys. Participants who had previous MI (n=734) or had emigrated before the date of examination (n=45) were excluded from the analyses. Participants who were still free of MI and attended the later surveys in 2001 to 2002 or in 2007 to 2008 had their CHD risk factor values updated at the date of their examination. The study was approved by the Regional Committee for Medical and Health Research Ethics and the Data Inspectorate of Norway. Each subject gave written informed consent.
Coronary Risk Factors
Each survey used a standardized almost-identical protocol including physical examination, blood sampling, and questionnaires. 11, 12 Blood pressure was measured with an automatic device. 12 Nonfasting blood samples were analyzed by standard methods at the University Hospital of Northern Norway. 12 Smoking status was self-reported in a questionnaire. Participants were defined as physically active if they performed strenuous physical activity (ie, became sweaty and breathless) at least 1 h/wk.
Identification and Validation of Incident CHD
Incident cases of CHD were recorded from each participant's study entry in 1994 to 1995, 2001 to 2002, or 2007 to 2008 until December 31, 2010. Adjudication of hospitalized and out-of hospital events was performed by an independent end-point committee using medical records and medical notes, autopsy records, and death certificates. The national unique 11-digit identification number allowed linkage to national and local diagnosis registries. Cases of CHD were identified by linkage to the discharge diagnosis registry at the University Hospital of Northern Norway, the only hospital in the area, with search for International Classification of Diseases, 10th Revision codes I20 to I25, I46, R96, R98, and R99. Modified World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease (MONICA)/MONICA Risk, Genetics, Archiving and Monograph (MORGAM) criteria were used and included clinical symptoms and signs, findings in electrocardiograms, values of cardiac biomarkers, and autopsy reports when applicable (http:// www.thl.fi/publications/morgam/manual/contents.htm).
Biomarkers considered were creatine kinase, its myocardial fraction (creatine kinase-MB), and troponin T beginning in 1999. Biomarker increases associated with revascularization procedures were not included as MI. The National Causes of Death Registry allowed identification of fatal cases of MI that occurred as out-of-hospital deaths and provided information on all-cause mortality. Death certificate information was used to collect relevant information from additional sources such as autopsy reports and records from nursing homes, ambulance services, and general practitioners. We classified hospitalized STEMI and non-STEMI by using standard criteria. 13 Out-of-hospital sudden death was defined as death caused by a probable MI (based on symptoms or autopsy) within 24 hours of symptom onset in nonhospitalized individuals or deaths in individuals brought to hospital with a cardiac arrest and unsuccessful resuscitation with no evidence of a noncoronary cause of death. Case fatality was defined as the proportion of incident CHDs that were fatal within 28 days. Dates of emigration were obtained from the Population Registry of Norway.
Statistical Analysis
Statistical analyses were performed with STATA 12 (StataCorp LP, College Station, TX) and SAS 9.3 (SAS Institute, Cary, NC). Age-and sex-adjusted means or prevalence of risk factors over time was estimated from generalized estimating equations to account for dependencies between repeated observations. The identity and logit link functions were used for continuous and binary variables, respectively, and the estimates were calculated with the use of the mean value for age and sex (57.9 years and 46% male) in the regression models. Follow-up extended from study entry to the date of incident event, date of emigration, death, or end of follow-up, whichever came first. Hazard ratios of CHD for coronary risk factors were estimated with Cox proportional hazards regression adjusted for age and sex. Hazard ratios of subtypes of CHD were estimated with the augmented data approach. 14 The proportional hazard assumption was verified by Schoenfeld residuals.
For incidence analysis, we used the split function to produce a new record for each follow-up year for each person, and age was updated every year that the participants were under follow-up. Crude event rates were estimated as the number of events per 100 000 person-years. Time trends in event and mortality rates and case fatality proportions were age and sex standardized with the Tromsø population in 2007 used as the standard population for the first 2 end points and the CHD event cohort for the last end point. We used a symmetrical moving average with a span of 5. This means that we calculated the average of the first 2 lagged values, the current value, and the first 2 forward terms of the series, with each term in the average receiving a weight of 1. The CHD mortality decline explained by out-of-hospital sudden deaths was estimated as the difference in out-of-hospital sudden death rate between 2010 and 1995 divided by the difference in total CHD mortality rate between 2010 and 1995. The proportion of the CHD mortality decline that was explained by the decline in incidence rates or case fatality was calculated as in the MONICA study: The average annual change in mortality rate is the sum of the average annual changes in event rate and case fatality proportion, expressed as percentages. 15 Poisson regression models were used to estimate linear time trends in events.
The proportion of the CHD incidence decline that was explained by change in each risk factor could be determined in those who participated in the 1994-1995 survey and was estimated by the expression (β0−β1)/β0. We used the same long data set as for the incidence analyses described previously. The βs are time-trend coefficients from Poisson regression models, the former adjusted for age and sex and the latter with additional adjustment for risk factors added to the model as time-dependent covariates. End of follow-up was defined as 2001 for those who did not attend the 2001-2002 survey and as 2007 for those who did not attend the 2007-2008 survey. Individuals who had a CHD event were censored from the analyses at the time of their event. One thousand bootstrapped samples were simulated (with replacement) to estimate the 95% confidence interval (CI) for the explained decline. A 2-sided significance level was used.
Results
We identified 1845 patients (39% women) with an incident CHD event between 1995 and 2010, representing a period of 375 064 person-years (Table 1) . Seventy-eight percent of the patients (n=1441) were hospitalized. Among those were 523 patients (36%) with STEMI, 869 (60%) with non-STEMI, and 49 with unclassifiable MI. A total of 236 hospitalized patients (16%) died within 28 days. Among the 404 nonhospitalized patients, there were 332 out-of-hospital sudden deaths and 341 deaths within 28 days after symptom onset. Thus, 58% of all fatal incident CHD events occurred as an out-of-hospital sudden death.
CHD Mortality
CHD mortality declined from 137 cases per 100 000 person-years in 1995 to 65 cases per 100 000 person-years in 2010 (P<0.001); out-of-hospital sudden death declined from 89 cases per 100 000 person-years in 1995 to 42 cases per 100 000 person-years in 2010 (P<0.001); and mortality rates among hospitalized MI patients declined from 50 cases per 100 000 person-years in 1995 to 28 cases per 100 000 person-years in 2010 (P<0.001; Figure, A). Thus, 65% of the decline in CHD mortality was attributable to a decrease in the rates of out-of-hospital sudden deaths.
Using Poisson regression models, we found that the ageand sex-standardized CHD mortality rate fell by 7.3% annually (95% CI, 5.6-8.9; P<0.001 for linear trend), the incidence of total CHD by 3.0% annually (95% CI, 2.0-4.0; P<0.001 January 5, 2016 for linear trend), and case fatality by 4.0% annually (95% CI, 2.2-5.7; P<0.001 for linear trend; Figure, A-C). Thus, changes in incidence and case fatality contributed 43% and 57%, respectively, to the decline in CHD mortality.
Incidence of CHD
The age-and sex-adjusted incidence of hospitalized STEMI decreased from 132 cases per 100 000 person-years in 1995 to 80 cases per 100 000 person-years in 2010 (average annual decrease, 4.3%; 95% CI, 2.5-6.1; P value for linear trend <0.001; Figure, B ). Similarly, there was a 7.6% (95% CI, 5.5-9.8; P value for linear trend <0.001) annual decline in outof-hospital sudden death. In contrast, hospitalizations for non-STEMI increased from 120 cases per 100 000 person-years in 1995 to a peak of 203 cases per 100 000 person-years in 2003, followed by yearly decreases to 144 cases per 100 000 personyears in 2010. The increase in hospitalization for non-STEMI in the first half of the study period led to increased incidence rates for total CHD from 367 cases per 100 000 person-years in 1995 to a peak of 431 cases per 100 000 in 2000, then decreasing each year to 280 cases per 100 000 in 2010 (Figure, B ).
Pre-Event Coronary Risk Factor Levels and Manifestations of CHD
Coronary risk factors were associated differently with out-ofhospital sudden death, hospitalized STEMI, and hospitalized non-STEMI (Table 2) . Participants with sudden death were older, had higher resting heart rates, and were less likely to be physically active than those with STEMI or non-STEMI. Male sex, hyperlipidemia, and smoking were more strongly associated with STEMI than with non-STEMI and sudden death. Overweight was associated with increased risk of STEMI and non-STEMI but not with sudden death. Angina pectoris was a stronger risk factor for non-STEMI than for STEMI.
Changes in Coronary Risk Factors and the Decline in CHD
Major coronary risk factors changed favorably during the study period (Table 3 ). Mean levels of cholesterol, blood pressure, resting heart rate, and smoking were reduced, and physical activity was increased. In contrast, overweight and diabetes mellitus increased.
The proportion of the decline in the incidence of CHD that was attributable to changes in risk factors is presented in Table 4 . The largest single contribution was declining cholesterol, which accounted for 32% of the observed 51% decline in incident CHD between 1995 and 2010. Changes in systolic blood pressure, smoking, resting heart rate, and physical activity each accounted for 9% to 14% of the decline in risk of CHD. Increases in body mass index and the prevalence of diabetes mellitus were associated with 7% and 2% increase in the risk of CHD, respectively. All risk factors together accounted for 66% of the decline in the incidence of CHD (Table 4) : 64% in women and 61% in men (Tables II and III in the online-only  Data Supplement) .
Characteristics and Treatments of Hospitalized Patients
Peak creatine kinase levels was stable over time in patients with STEMI but decreased significantly in patients with non-STEMI, indicating that non-STEMIs became smaller in the latter part of the period ( Table 5 ). The proportion of patients who developed Q waves on ECG decreased significantly over time among patients with both STEMI and non-STEMI. Revascularization and the proportion of patients receiving β-blockers, acetylsalicylic acid, and statins at discharge increased over time. Age-and sex-adjusted 28-day case fatality decreased by 26% (P=0.38) in STEMI patients and by 43% (P=0.01) in non-STEMI patients in 2005 to 2010 compared with 1995 to 1999.
Discussion
We found a substantial decline in CHD mortality between 1995 and 2010 that was driven by significant reductions in the incidence of out-of-hospital sudden death and STEMI. Changes in cardiovascular risk factors accounted for 66% of the change in hospitalized and nonhospitalized fatal and nonfatal CHD, with an upper CI close to 100%. This study thus extends results of previous studies that found modifiable risk factors to account for most cases of hospitalized, nonfatal MI. 16 In line with others, we found that changes in the rates of out-of-hospital sudden death had a stronger impact on CHD mortality trends than changes in mortality of hospitalized patients. 17 The study demonstrates that primary prevention by modification of risk factors by means of a healthy lifestyle or medication will influence both incident CHD and case fatality †Percentage of the observed decline in risk explained by the risk factors=100%×(β0−β1)/β0, where β0 is the coefficient for calendar time in the model with adjustment for age and sex only (model 1) and β1 is the coefficient for calendar time in the model with additional adjustment for the risk factor(s).
‡The 95% CI are estimated with 1000 bootstrapped samples. in populations, shown by the association between coronary risk factors and out-of-hospital sudden deaths. Thus, sudden death is a preventable condition. 18, 19 We found that cardiovascular risk factors had different impacts on subtypes of CHD, suggesting that the spectrum of CHD manifestations among populations and over time may differ, depending on the relative prevalence of the risk factors. Our findings suggest that reduced prevalences of hypercholesterolemia and smoking are major driving forces for the decline in the incidence of STEMI, indicating that primary prevention efforts result in fewer severe events. 20, 21 In line with this, others have found that cholesterol is associated with rupture of vulnerable plaques and that smoking is associated with coronary thrombosis. 19 Higher resting heart rate was more strongly associated with out-of-hospital sudden death than with STEMI or non-STEMI ( Table 2 ). Higher heart rates are associated with myocardial ischemia, ventricular arrhythmias, and coronary atherosclerosis. [22] [23] [24] Correspondingly, we found that physical activity, which lowers resting heart rate, was associated with a lower risk of out-of-hospital sudden death and accounted for 9% of the decline in total CHD. The prevalence of selfreported angina pectoris fell by 29% ( Table 3 ), suggesting that risk factor changes led to the less coronary atherosclerosis.
As observed earlier, we found an increasing incidence of non-STEMI in the first part of the study period, 21, 25, 26 likely reflecting the use of more sensitive biomarkers that detect smaller myocardial necrosis. This is supported by declining peak creatine kinase levels among non-STEMI patients, whereas the levels were stable in STEMI patients. We believe that the decline in STEMI is real and that the initial changes in non-STEMI reflect increased diagnostic sensitivity.
A strength of our study is that we used data on an individual level from a population-based study with a high attendance rate and standardized survey methods. In addition, case finding followed a standardized protocol for ascertainment of out-of-hospital and hospitalized events. The inclusion of incident cases only reduces the possibility that previous cardiovascular disease might have affected the risk factor levels. Finally, loss to follow-up is negligible because hospital treatment in Norway is free of charge and because of the use of the unique personal identity number to search official health registries.
Our study has limitations. We have included a largely homogeneous population from Norway that is distinct from the US population in which the rate of physical activity is lower, the rate of obesity is greater, and the smoking rate is lower. The autopsy rate for individuals with out-of-hospital deaths in our study was low (9%). This can lead to misclassifications even if the predominant cause of sudden death is CHD. 18, 27, 28 In addition, the true effect of changes in diagnostic sensitivity of biomarkers could not be fully quantified. The potential bias from this would be an overestimation of the incidence of MI in later years. The associations between trends in CHD and risk factors were necessarily based on attendees in subsequent surveys and not the entire source population, which could have introduced response and survival biases. The analysis was based on the assumption that the effects of changes in risk factors on CHD outcomes occurred within the time between consecutive surveys (≈6 years) or between the last survey and 2010 (≈3 years). Figure 1 . A, Trends in annual incidence rates of total coronary heart disease (CHD) mortality, out-of-hospital sudden death, and hospitalized fatal myocardial infarctions (MIs), 1995 to 2010, the Tromsø Study. The incidence rates are fitted as 5 years-moving mean. Each bar represents 95% confidence intervals. Rates are directly age-and sex-standardized to the Tromsø population. B, Trends in annual incidence rates of coronary heart disease, 1995 to 2010, the Tromsø Study. The incidence rates are fitted as 5 years-moving mean. Each bar represents 95% confidence intervals. Rates are directly age-and sex-standardized to the Tromsø population. STEMI indicates ST-segment-elevation myocardial infarction. C, Trends in annual case fatality proportion, 1995 to 2010, the Tromsø Study. The case fatality proportions are fitted as 5 years-moving mean and directly age-and sex-standardized with the event cohort as the standard population. Each bar represents 95% confidence intervals. January 5, 2016
This might underestimate the effects of a risk factor change if a lag time of >3 to 5 years is present before the benefits of a risk factor change are realized. However, substantial benefits from smoking cessation, changes in blood lipids, and changes in blood pressure have been observed within 1 to 3 years. 29, 30 
Conclusions
The substantial decline in CHD mortality was driven by significant reductions in the incidence of out-of-hospital sudden death and hospitalized STEMI and by a significant reduction in case fatality among hospitalized patients. The decline in event rates and the decline in case fatality each explained 50% of the decline in CHD mortality. Favorable changes in modifiable risk factors accounted for 66% of the decline in fatal and nonfatal CHD events in this population.
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